The table below shows Immunocore Holdings plc's income statement line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Revenue
-
-
$249.43M
$174.36M
$36.48M
Cost of revenue
$5.09M
$2.73M
$1.04M
$1.09M
$0.00
Gross profit
-
-
-
-
-
R&D
$274.87M
$222.15M
$163.54M
$101.92M
$100.25M
SG&A
$165.41M
$155.78M
$144.50M
$123.06M
$110.82M
IMCR annual revenue (10-K history)
Immunocore Holdings plc reported annual revenue of $400.02M for fiscal year 2025. That is up 29.0% from $310.20M in fiscal 2024. Over the 5 fiscal years shown, annual revenue grew from $36.48M (FY 2021) to $400.02M. Figures come from the company's audited annual reports as filed with the SEC.